Minipress xl side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Minipress xl. Common side effects include cardiac arrest among females and cardiac arrest among males.
The phase IV clinical study is created by eHealthMe based on 204 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
204 people who take Minipress Xl and have side effects are studied.
What is Minipress Xl?
Minipress xl has active ingredients of prazosin hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 225 Minipress xl users for its effectiveness, alternative drugs and more.
Number of Minipress xl reports submitted per year:

Minipress xl side effects by time on the drug *:
Minipress xl side effects by gender *:
Minipress xl side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Minipress xl?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on prazosin hydrochloride (the active ingredients of Minipress xl) and Minipress xl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Minipress xl:
- Minipress xl (225 reports)
All Minipress xl side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ibu and Zembrace Symtouch drug interaction - 7 seconds ago
- Erelzi and Xalatan drug interaction - 19 seconds ago
- Duoneb vs. Ventolin Hfa - 22 seconds ago
- Ultravist 150 and Staphylococcal Infection - 27 seconds ago
- Valsartan And Hydrochlorothiazide and Irritability - 30 seconds ago